FEN-1 endonucleases, mixtures and cleavage methods

• US 8,182,991 B1
• Filed: 10/06/2000
• Issued: 05/22/2012
• Est. Priority Date: 11/26/1997
• Status: Expired due to Fees

• Current Assignee: Gen-Probe Incorporated (Hologic Incorporated)
• Original Assignee: Third Wave Technologies Incorporated (Hologic Incorporated)
• Inventors: Kaiser, Michael W., Lyamicheva, Natasha, Lyamichev, Victor I.
• Primary Examiner(s): Staples, Mark
• Application Number:
  US09/684,305
• Time in Patent Office: 4,246 Days
• Field of Search: None
• US Class Current: 435/6.12
• CPC Class Codes: C12N 9/22 Ribonucleases RNAses, DNAses catalytic nucleic acids C12N15/113
• CPC Class Codes: C12Q 1/6816 characterised by the detection means C12Q1/6804 takes precedence
• CPC Class Codes: C12Q 2521/301 Endonuclease
• CPC Class Codes: C12Q 2527/125 Specific component of sample, medium or buffer

Abstract

The present invention relates to means for the detection and characterization of nucleic acid sequences, as well as variations in nucleic acid sequences. The present invention also relates to improved cleavage means for the detection and characterization of nucleic acid sequences. Structure-specific nucleases derived from a variety of thermostable organisms are provided. These structure-specific nucleases are used to cleave target-dependent cleavage structures, thereby indicating the presence of specific nucleic acid sequences or specific variations thereof.

Claims

1. A method for treating nucleic acid, comprising:

a) providing;

i) a purified archaeal FEN-1 endonuclease; and

ii) a nucleic acid substrate;

b) treating said nucleic acid substrate under conditions such that said substrate forms one or more cleavage structures; and

c) reacting said endonuclease with said cleavage structures so that one or more cleavage products are produced,

wherein said archaeal FEN-1 endonuclease comprises an Archaeoglobus fulgidus FEN-1 endonuclease.

2. The method of claim 1, wherein said Archaeoglobus fulgidus FEN-1 endonuclease comprises SEQ ID NO:

179.

3. The method of claim 1, wherein said purified archaeal FEN-1 endonuclease is provided as part of a mixture, said mixture further comprising a second structure-specific nuclease, wherein said reacting said endonuclease with said cleavage structures in step c) comprises reacting said cleavage structure with said mixture.

4. The method of claim 3, wherein said second structure-specific nuclease comprises a polymerase.

5. The method of claim 4, wherein said polymerase comprises a thermostable polymerase.

6. The method of claim 5, wherein said thermostable polymerase comprises a thermostable DNA polymerase altered in amino acid sequence such that it exhibits reduced DNA synthetic activity from that of a corresponding wild-type DNA polymerase but retains substantially the same 5′

nuclease activity of said wild-type DNA polymerase.

7. The method of claim 1, wherein said nucleic acid of step (a) is substantially single stranded.

8. The method of claim 1, wherein said nucleic acid of step (a) is double stranded.

9. The method of claim 8, wherein said treating of step (b) comprises:

i) rendering said double-stranded nucleic acid substantially single-stranded; and

ii) exposing said single-stranded nucleic acid to conditions such that said single-stranded nucleic acid has secondary structure.

10. The method of claim 9, wherein said double stranded nucleic acid is rendered substantially single-stranded by the use of increased temperature.

11. The method of claim 1, further comprising the step of detecting at least one of said one or more cleavage products.

12. A method for treating nucleic acid, comprising:

a) providing;

i) a purified archaeal FEN-1 endonuclease;

ii) a source of a target nucleic acid, said target nucleic acid comprising first and second portions, wherein said second portion is downstream of and contiguous to said first portion;

iii) a first oligonucleotide comprising a 5′

portion complementary to said first portion of said target nucleic acid; and

iv) a second oligonucleotide comprising a 3′

portion and a 5′

portion, wherein said 5′

portion is complementary to said second portion of said target nucleic acid;

b) generating a cleavage structure wherein at least said 5′

portion of said first oligonucleotide is annealed to said first portion of said target nucleic acid and wherein at least said 5′

portion of said second oligonucleotide is annealed to said second portion of said target nucleic acid; and

c) exposing said cleavage structure to said FEN-1 endonuclease to generate a cleavage product,

wherein said archaeal FEN-1 endonuclease comprises Archaeoglobus fulgidus FEN-1 endonuclease.

13. The method of claim 12, further comprising the step of d) detecting said cleavage product.

14. The method of claim 12, further comprising the step of generating a second cleavage structure, said second cleavage structure comprising said cleavage product hybridized to a third oligonucleotide.

15. The method of claim 14, further comprising the step of exposing said second cleavage structure to said FEN-1 endonuclease to generate a second cleavage product.

16. The method of claim 15, further comprising the step of detecting said second cleavage product.

17. The method of claim 12, wherein said Archaeoglobus fulgidus FEN-1 endonuclease comprises SEQ ID NO:

179.

18. The method of claim 12, wherein said 3′

portion of said second oligonucleotide comprises a 3′

terminal nucleotide not complementary to said target nucleic acid.

19. The method of claim 12, wherein said 3′

portion of said second oligonucleotide consists of a single nucleotide not complementary to said target nucleic acid.

20. The method of claim 12, wherein at least one of said first oligonucleotide and said second oligonucleotide is attached to a solid support.